Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus

References

• Lowy FD. Staphylococcus aureus Infections. N Engl J Med 1998; 339:520-32; PMID:9709046; http://dx.doi.org/10.1056/NEJM199808203390806
   PubMed Web of Science ®Google Scholar
• DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 2010; 375:1557-68; PMID:20206987; http://dx.doi.org/10.1016/S0140-6736(09)61999-1
   PubMed Web of Science ®Google Scholar
• Otter JA, French GL. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis 2010; 10:227-39; PMID:20334846; http://dx.doi.org/10.1016/S1473-3099(10)70053-0
   PubMed Web of Science ®Google Scholar
• Bassetti M, Nicco E, Mikulska M. Why is community-associated MRSA spreading across the world and how will it change clinical practice? Int J Antimicrob Agents 2009; 34:S15-S9; PMID:19560669; http://dx.doi.org/10.1016/S0924-8579(09)70544-8
   PubMed Web of Science ®Google Scholar
• Schlievert PM. Staphylococcal toxic shock syndrome: still a problem. Med J Aust 2005; 182:651-2; PMID:16116687
   PubMed Web of Science ®Google Scholar
• Tierno PM, Jr, Schlievert PM, Tripp TJ, Peterson ML. Reemergence of Staphylococcal Toxic Shock Syndrome in the United States since 2000. J Clin Microbiol 2005; 43:2032-3; PMID:15815055; http://dx.doi.org/10.1128/JCM.43.4.2032-2033.2005
   PubMed Web of Science ®Google Scholar
• Yok-Al Que, Moreill P. Staphylococcus aureus (Including Staphylococcal Toxic Shock). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia: Churchill Livingstone, Elsevier, 2009.
   Google Scholar
• Melamed A, Sorvillo F. The burden of sepsis-associated mortality in the United States from 1999 to 2005: an analysis of multiple-cause-of-death data. Critical Care 2009; 13:R28; PMID:19250547; http://dx.doi.org/10.1186/cc7733
   PubMed Web of Science ®Google Scholar
• Sugiyama Y, Okii K, Murakami Y, Yokoyama T, Takesue Y, Ohge H, Sueda T, Hiyama E. Changes in the agr Locus Affect Enteritis Caused by Methicillin-Resistant Staphylococcus aureus. J Clin Microbiol 2009; 47:1528-35; PMID:19297601; http://dx.doi.org/10.1128/JCM.01497-08
   PubMed Web of Science ®Google Scholar
• Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DY. Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol 2010; 125:39-49; PMID:20109735; http://dx.doi.org/10.1016/j.jaci.2009.10.039
   PubMed Web of Science ®Google Scholar
• Schlievert PM. Cytolysins, superantigens, and pneumonia due to community-associated methicillin-resistant Staphylococcus aureus. J Infect Dis 2009; 200:676-8; PMID:19653828; http://dx.doi.org/10.1086/605333
   PubMed Web of Science ®Google Scholar
• Nagao M, Okamoto A, Yamada K, Hasegawa T, Hasegawa Y, Ohta M. Variations in amount of TSST-1 produced by clinical methicillin resistant Staphylococcus aureus (MRSA) isolates and allelic variation in accessory gene regulator (agr) locus. BMC Microbiol 2009; 9:52; PMID:19272162; http://dx.doi.org/10.1186/1471-2180-9-52
   PubMed Web of Science ®Google Scholar
• Cai Y, Kong F, Wang Q, Tong Z, Sintchenko V, Zeng X, Gilbert GL. Comparison of single- and multilocus sequence typing and toxin gene profiling for characterization of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2007; 45:3302-8; PMID:17715374; http://dx.doi.org/10.1128/JCM.01082-07
   PubMed Web of Science ®Google Scholar
• Shukla SK, Karow ME, Brady JM, Stemper ME, Kislow J, Moore N, Wroblewski K, Chyou P-H, Warshauer DM, Reed KD, et al. Virulence Genes and Genotypic Associations in Nasal Carriage, Community-Associated Methicillin-Susceptible and Methicillin-Resistant USA400 Staphylococcus aureus Isolates. J Clin Microbiol 2010; 48:3582-92; PMID:20668125; http://dx.doi.org/10.1128/JCM.00657-10
   PubMed Web of Science ®Google Scholar
• Mushtaq F, Hildrew S, Okugbeni G, Ellis RW. Necrotizing haemorrhagic pneumonia proves fatal in an immunocompetent child due to Panton–Valentine Leucocidin, toxic shock syndrome toxins 1 and 2 and enterotoxin C-producing Staphylococcus aureus. Acta Pædiatrica 2008; 97:985-7; http://dx.doi.org/10.1111/j.1651-2227.2008.00797.x
   PubMed Web of Science ®Google Scholar
• Pozzi C, Lofano G, Mancini F, Soldaini E, Speziale P, De Gregorio E, Rappuoli R, Bertholet S, Grandi G, Bagnoli F. Phagocyte subsets and lymphocyte clonal deletion behind ineffective immune response to Staphylococcus aureus. FEMS Microbiol Rev 2015; 39:750; PMID:25994610; http://dx.doi.org/10.1093/femsre/fuv024
   PubMed Web of Science ®Google Scholar
• van Langevelde P, van Dissel J, Meurs C, Renz J, Groeneveld P. Combination of flucloxacillin and gentamicin inhibits toxic shock syndrome toxin 1 production by Staphylococcus aureus in both logarithmic and stationary phases of growth. Antimicrob Agents Chemother 1997; 41:1682-5; PMID:9257741
   PubMed Web of Science ®Google Scholar
• Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes Analysis of Delayed Antibiotic Treatment for Hospital-Acquired Staphylococcus aureus Bacteremia. Clin Infect Dis 2003; 36:1418-23; PMID:12766837; http://dx.doi.org/10.1086/375057
   PubMed Web of Science ®Google Scholar
• Moskowitz SM, Wiener-Kronish JP. Mechanisms of bacterial virulence in pulmonary infections. Curr Opin Crit Care 2010; 16:8-12; PMID:19956071; http://dx.doi.org/10.1097/MCC.0b013e3283354710
   PubMed Web of Science ®Google Scholar
• Ragle BE, Bubeck Wardenburg J. Anti-Alpha-Hemolysin Monoclonal Antibodies Mediate Protection against Staphylococcus aureus Pneumonia. Infect Immun 2009; 77:2712-8; PMID:19380475; http://dx.doi.org/10.1128/IAI.00115-09
   PubMed Web of Science ®Google Scholar
• Hua L, Hilliard JJ, Shi Y, Tkaczyk C, Cheng LI, Yu X, Datta V, Ren S, Feng H, Zinsou R, et al. Assessment of an Anti-Alpha-Toxin Monoclonal Antibody for Prevention and Treatment of Staphylococcus aureus-Induced Pneumonia. Antimicrob Agents and Chemother 2014; 58:1108-17; PMID:24295977; http://dx.doi.org/10.1128/AAC.02190-13
   PubMed Web of Science ®Google Scholar
• Labandeira-Rey M, Couzon F, Boisset S, Brown EL, Bes M, Benito Y, Barbu EM, Vazquez V, Höök M, Etienne J, et al. Staphylococcus aureus Panton-Valentine Leukocidin Causes Necrotizing Pneumonia. Science 2007; 315:1130-3; PMID:17234914; http://dx.doi.org/10.1126/science.1137165
   PubMed Web of Science ®Google Scholar
• Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, Schneewind O, DeLeo FR. Panton-Valentine Leukocidin Is Not a Virulence Determinant in Murine Models of Community-Associated Methicillin-Resistant Staphylococcus aureus Disease. J Infect Dis 2008; 198:1166-70; PMID:18729780; http://dx.doi.org/10.1086/592053
   PubMed Web of Science ®Google Scholar
• Voyich Jovanka M, Otto M, Mathema B, Braughton Kevin R, Whitney Adeline R, Welty D, Long RD, Dorward David W, Gardner Donald J, Lina G, et al. Is Panton-Valentine Leukocidin the Major Virulence Determinant in Community Associated Methicillin Resistant Staphylococcus aureus Disease?. J Infect Dis 2006; 194:1761-70; PMID:17109350; http://dx.doi.org/10.1086/509506
   PubMed Web of Science ®Google Scholar
• Yoong P, Pier GB. Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection. Proc Natl Acad Sci U S A 2010; 107:2241-6; PMID:20133867; http://dx.doi.org/10.1073/pnas.0910344107
   PubMed Web of Science ®Google Scholar
• Parker D, Ryan CL, Alonzo F, Torres VJ, Planet PJ, Prince AS. CD4+ T Cells Promote the Pathogenesis of Staphylococcus aureus Pneumonia. J Infect Dis 2015; 211:835-45; PMID:25240171; http://dx.doi.org/10.1093/infdis/jiu525
   PubMed Web of Science ®Google Scholar
• Tilahun AY, Karau MJ, Clark CR, Patel R, Rajagopalan G. The impact of tacrolimus on the immunopathogenesis of staphylococcal enterotoxin-induced systemic inflammatory response syndrome and pneumonia. Microbes Infect 2012; 14:528-36; PMID:22273732; http://dx.doi.org/10.1016/j.micinf.2012.01.001
   PubMed Web of Science ®Google Scholar
• Spaulding AR, Salgado-Pabón W, Merriman JA, Stach CS, Ji Y, Gillman AN, Peterson ML, Schlievert PM. Vaccination Against Staphylococcus aureus Pneumonia. J Infect Dis 2014; 209:1955-62; PMID:24357631; http://dx.doi.org/10.1093/infdis/jit823
   PubMed Web of Science ®Google Scholar
• CDC. Four Pediatric Deaths From Community-Acquired Methicillin-Resistant Staphylococcus aureus, Minnesota and North Dakota, 1997–1999. MMWR Morb Mortal Week Rep 1999; 48:707-10.
   PubMedGoogle Scholar
• Fey PD, Said-Salim B, Rupp ME, Hinrichs SH, Boxrud DJ, Davis CC, Kreiswirth BN, Schlievert PM. Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47:196-203; PMID:12499191; http://dx.doi.org/10.1128/AAC.47.1.196-203.2003
   PubMed Web of Science ®Google Scholar
• Proft T, Fraser JD. Bacterial superantigens. Clin Exp Immunol 2003; 133:299-306; PMID:12930353; http://dx.doi.org/10.1046/j.1365-2249.2003.02203.x
   PubMed Web of Science ®Google Scholar
• Foster TJ. Immune evasion by staphylococci. Nat Rev Micro 2005; 3:948-58; http://dx.doi.org/10.1038/nrmicro1289
   PubMed Web of Science ®Google Scholar
• Fraser J, Arcus V, Kong P, Baker E, Proft T. Superantigens - powerful modifiers of the immune system. Mol Med Today 2000; 6:125-32; PMID:10689316; http://dx.doi.org/10.1016/S1357-4310(99)01657-3
   PubMedGoogle Scholar
• Thomas D, Dauwalder O, Brun V, Badiou C, Ferry T, Etienne J, Vandenesch F, Lina G. Staphylococcus aureus Superantigens Elicit Redundant and Extensive Human V{beta} Patterns. Infect Immun 2009; 77:2043-50; PMID:19255190; http://dx.doi.org/10.1128/IAI.01388-08
   PubMed Web of Science ®Google Scholar
• Buonpane RA, Churchill HRO, Moza B, Sundberg EJ, Peterson ML, Schlievert PM, Kranz DM. Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists. Nat Med 2007; 13:725-9; PMID:17515896; http://dx.doi.org/10.1038/nm1584
   PubMed Web of Science ®Google Scholar
• Arad G, Hillman D, Levy R, Kaempfer R. Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock. J Leukoc Biol 2001; 69:921-7; PMID:11404377
   PubMed Web of Science ®Google Scholar
• DaSilva L, Welcher BC, Ulrich RG, Aman MJ, David CS, Bavari S. Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines. J Infect Dis 2002; 185:1754-60; PMID:12085321; http://dx.doi.org/10.1086/340828
   PubMed Web of Science ®Google Scholar
• Krakauer T. Therapeutic Down-Modulators of Staphylococcal Superantigen-Induced Inflammation and Toxic Shock. Toxins 2010; 2:1963-83; PMID:22069668; http://dx.doi.org/10.3390/toxins2081963
   PubMed Web of Science ®Google Scholar
• Tilahun ME, Rajagopalan G, Shah-Mahoney N, Lawlor RG, Tilahun AY, Xie C, Natarajan K, Margulies DH, Ratner DI, Osborne BA, et al. Potent neutralization of staphylococcal enterotoxin B by synergistic action of chimeric antibodies. Infect Immun 2010; 78:2801-11; PMID:20308304; http://dx.doi.org/10.1128/IAI.01121-09
   PubMed Web of Science ®Google Scholar
• Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000; 13:16-34; PMID:10627489; http://dx.doi.org/10.1128/CMR.13.1.16-34.2000
   PubMed Web of Science ®Google Scholar
• Lee VT, Chang AH, Chow AW. Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates. J Infect Dis 1992; 166:911-5; PMID:1527429; http://dx.doi.org/10.1093/infdis/166.4.911
   PubMed Web of Science ®Google Scholar
• Tilahun ME, Kwan A, Natarajan K, Quinn M, Tilahun AY, Xie C, Margulies DH, Osborne BA, Goldsby RA, Rajagopalan G. Chimeric Anti-Staphylococcal Enterotoxin B Antibodies and Lovastatin Act Synergistically to Provide In Vivo Protection against Lethal Doses of SEB. PLoS One 2011; 6:e27203; PMID:22102880; http://dx.doi.org/10.1371/journal.pone.0027203
   PubMed Web of Science ®Google Scholar
• Varshney AK, Wang X, Cook E, Dutta K, Scharff MD, Goger MJ, Fries BC. Generation, characterization, and epitope mapping of neutralizing and protective monoclonal antibodies against staphylococcal enterotoxin B-induced lethal shock. J Biol Chem 2011; 286:9737-47; PMID:21233204; http://dx.doi.org/10.1074/jbc.M110.212407
   PubMed Web of Science ®Google Scholar
• Karauzum H, Chen G, Abaandou L, Mahmoudieh M, Boroun AR, Shulenin S, Devi VS, Stavale E, Warfield KL, Zeitlin L, et al. Synthetic Human Monoclonal Antibodies toward Staphylococcal Enterotoxin B (SEB) Protective against Toxic Shock Syndrome. J Biol Chem 2012; 287:25203-15; PMID:22645125; http://dx.doi.org/10.1074/jbc.M112.364075
   PubMed Web of Science ®Google Scholar
• Drozdowski B, Zhou Y, Kline B, Spidel J, Chan YY, Albone E, Turchin H, Chao Q, Henry M, Balogach J, et al. Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B. J Immune Based Ther Vaccines 2010; 8:9-; PMID:21176153; http://dx.doi.org/10.1186/1476-8518-8-9
   PubMedGoogle Scholar
• Graef RR, Anderson GP, Doyle KA, Zabetakis D, Sutton FN, Liu JL, Serrano-González J, Goldman ER, Cooper LA. Isolation of a Highly Thermal Stable Lama Single Domain Antibody Specific for Staphylococcus aureus Enterotoxin B. BMC Biotechnol 2011; 11:86-; PMID:21933444; http://dx.doi.org/10.1186/1472-6750-11-86
   PubMed Web of Science ®Google Scholar
• Varshney AK, Wang X, Scharff MD, MacIntyre J, Zollner RS, Kovalenko OV, Martinez LR, Byrne FR, Fries BC. Staphylococcal Enterotoxin B–Specific Monoclonal Antibody 20B1 Successfully Treats Diverse Staphylococcus aureus Infections. J Infect Dis 2013; 208:2058-66; PMID:23922375; http://dx.doi.org/10.1093/infdis/jit421
   PubMed Web of Science ®Google Scholar
• Fraser JD. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature 1989; 339:221-3; PMID:2785644; http://dx.doi.org/10.1038/339221a0
   PubMed Web of Science ®Google Scholar
• Tilahun AY, Marietta EV, Wu TT, Patel R, David CS, Rajagopalan G. Human leukocyte antigen class II transgenic mouse model unmasks the significant extrahepatic pathology in toxic shock syndrome. Am J Pathol 2011; 178:2760-73; PMID:21641398; http://dx.doi.org/10.1016/j.ajpath.2011.02.033
   PubMed Web of Science ®Google Scholar
• Rajagopalan G, Sen M, David CS. In vitro and in vivo evaluation of staphylococcal superantigen peptide antagonisits. Infect Immun 2004; 72:6733-7; PMID:15501813; http://dx.doi.org/10.1128/IAI.72.11.6733-6737.2004
   PubMed Web of Science ®Google Scholar
• Tilahun AY, Chowdhary VR, David CS, Rajagopalan G. Systemic Inflammatory Response Elicited by Superantigen Destabilizes T Regulatory Cells, Rendering Them Ineffective during Toxic Shock Syndrome. J Immunol 2014; 193:2919-30; PMID:25092888; http://dx.doi.org/10.4049/jimmunol.1400980
   PubMed Web of Science ®Google Scholar
• Tilahun AY, Holz M, Wu TT, David CS, Rajagopalan G. Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-Induced toxic shock syndrome. PLoS One 2011; 6:e16764; PMID:21304813; http://dx.doi.org/10.1371/journal.pone.0016764
   PubMed Web of Science ®Google Scholar
• Tilahun AY, Marietta EV, Wu TT, Patel R, David CS, Rajagopalan G. Human leukocyte antigen class II transgenic mouse model unmasks the significant extrahepatic pathology in toxic shock syndrome. Am J Pathol 2011; 178:2760-73; PMID:21641398; http://dx.doi.org/10.1016/j.ajpath.2011.02.033
   PubMed Web of Science ®Google Scholar
• Karau MJ, Tilahun A, Schmidt S, Clark CR, Patel R, Rajagopalan G. Linezolid is Superior to Vancomycin in Experimental Pneumonia Caused by Superantigen-Producing Staphylococcus aureus in HLA class II Transgenic Mice. Antimicrob Agents Chemother 2012; 56:5401-5; PMID:22850509; http://dx.doi.org/10.1128/AAC.01080-12
   PubMed Web of Science ®Google Scholar
• Moran AE, Holzapfel KL, Xing Y, Cunningham NR, Maltzman JS, Punt J, Hogquist KA. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J Exp Med 2011; 208:1279-89; PMID:21606508; http://dx.doi.org/10.1084/jem.20110308
   PubMed Web of Science ®Google Scholar
• Kuehl WM, Bergsagel PL. Molecular pathogenesis of multiple myeloma and its premalignant precursor. J Clin Invest 2012; 122:3456-63; PMID:23023717; http://dx.doi.org/10.1172/JCI61188
   PubMed Web of Science ®Google Scholar
• Skurnik D, Kropec A, Roux D, Theilacker C, Huebner J, Pier GB. Natural Antibodies in Normal Human Serum Inhibit Staphylococcus aureus Capsular Polysaccharide Vaccine Efficacy. Clin Infect Dis 2012; 55:1188-97; PMID:22806596; http://dx.doi.org/10.1093/cid/cis624
   PubMed Web of Science ®Google Scholar
• Lehar SM, Pillow T, Xu M, Staben L, Kajihara KK, Vandlen R, DePalatis L, Raab H, Hazenbos WL, Hiroshi Morisaki J, et al. Novel antibody–antibiotic conjugate eliminates intracellular S. aureus. Nature 2015; 527:323-8; PMID:26536114; http://dx.doi.org/10.1038/nature16057
   PubMed Web of Science ®Google Scholar
• Dryla A, Prustomersky S, Gelbmann D, Hanner M, Bettinger E, Kocsis B, Kustos T, Henics T, Meinke A, Nagy E. Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin Diagn Lab Immunol 2005; 12:387-98; PMID:15753252
   PubMedGoogle Scholar
• Moravcova S, Kyle B, Shanahan H, Giannaris S, Smith A, Hamilton-Davies C. Variability of anti-staphylococcal antibodies in healthy volunteers and pre-cardiac surgery patients. Perioper Med 2016; 5:13; PMID:27239299; http://dx.doi.org/10.1186/s13741-016-0039-y
   PubMed Web of Science ®Google Scholar
• Linnér A, Darenberg J, Sjölin J, Henriques-Normark B, Norrby-Teglund A. Clinical Efficacy of Polyspecific Intravenous Immunoglobulin Therapy in Patients With Streptococcal Toxic Shock Syndrome: A Comparative Observational Study. Clin Infect Dis 2014; 59:851-7; http://dx.doi.org/10.1093/cid/ciu449
   PubMed Web of Science ®Google Scholar
• de Barros Miranda-Filho D, de Alencar Ximenes RA, Barone AA, Vaz VL, Vieira AG, Albuquerque VMG. Randomised controlled trial of tetanus treatment with antitetanus immunoglobulin by the intrathecal or intramuscular route. BMJ Br Med J 2004; 328:615; http://dx.doi.org/10.1136/bmj.38027.560347.7C
   PubMed Web of Science ®Google Scholar
• Jarboe J, Gupta A, Saif W. Therapeutic Human Monoclonal Antibodies Against Cancer. In: Steinitz M, ed. Human Monoclonal Antibodies: Methods and Protocols. Totowa, NJ: Humana Press, 2014:61-77.
   Google Scholar
• Kim CK, Karau MJ, Greenwood-Quaintance KE, Tilahun AY, Krogman A, David CS, Pritt B, Patel R, Rajagopalan G. Superantigen-Producing Staphylococcus aureus Elicits Systemic Immune Activation in a Murine Wound Colonization Model. Toxins 2015; 7:5308-19; PMID:26670252; http://dx.doi.org/10.3390/toxins7124886
   PubMed Web of Science ®Google Scholar
• Chung J-W, Greenwood-Quaintance KE, Karau MJ, Tilahun A, Khaleghi SR, Chowdhary VR, David CS, Patel R, Rajagopalan G. Superantigens Produced by Catheter-Associated Staphylococcus aureus Elicit Systemic Inflammatory Disease in the Absence of Bacteremia. J Leukoc Biol 2015; 98:271-81; PMID:25979434; http://dx.doi.org/10.1189/jlb.4A1214-577RR
   PubMed Web of Science ®Google Scholar
• Adhikari RP, Novick RP. Regulatory organization of the staphylococcal sae locus. Microbiology 2008; 154:949-59; PMID:18310041; http://dx.doi.org/10.1099/mic.0.2007/012245-0
   PubMed Web of Science ®Google Scholar